US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 2.2700
  • +0.0900+4.13%
Close Nov 1 16:00 ET
170.25MMarket Cap-2364P/E (TTM)

Context Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-41.64%3.09M
-42.65%3.82M
68.49%25.07M
78.58%6.93M
52.68%6.18M
50.87%5.29M
93.63%6.67M
100.07%14.88M
25.56%3.88M
158.16%4.05M
Selling and administrative expenses
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
114.43%7.79M
-3.38%1.74M
137.85%1.97M
-General and administrative expense
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
114.43%7.79M
-3.38%1.74M
137.85%1.97M
Research and development costs
-59.99%1.38M
-56.49%1.97M
150.77%17.78M
147.19%5.3M
115.89%4.49M
128.11%3.46M
235.53%4.53M
86.36%7.09M
65.80%2.14M
180.90%2.08M
Operating profit
41.64%-3.09M
42.65%-3.82M
-68.49%-25.07M
-78.58%-6.93M
-52.68%-6.18M
-50.87%-5.29M
-93.63%-6.67M
-100.07%-14.88M
-25.56%-3.88M
-158.16%-4.05M
Net non-operating interest income expense
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
951.91%547.27K
103,983.49%327.86K
15,345.44%192.25K
Non-operating interest income
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
--547.27K
--327.86K
--192.25K
Other net income (expense)
50.05%-6.11K
24.74%3.35K
88.93%-55.57K
-2,568.41%-61.4K
903.20%15.37K
97.55%-12.23K
316.95%2.69K
83.01%-502K
-733.70%-2.3K
-98.79%1.53K
Special income (charges)
----
----
--0
--0
--0
----
----
83.81%-500K
--0
--0
-Less:Other special charges
----
----
----
----
----
----
----
-83.81%500K
--0
----
Other non- operating income (expenses)
50.05%-6.11K
24.74%3.35K
-2,672.95%-55.57K
-2,568.41%-61.4K
903.20%15.37K
-305,775.00%-12.23K
316.95%2.69K
-101.62%-2K
-733.70%-2.3K
-98.79%1.53K
Income before tax
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
Income tax
Net income
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
Net income continuous Operations
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
Minority interest income
Net income attributable to the parent company
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
-167.14%-3.85M
Basic earnings per share
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
74.80%-0.93
-13.61%-0.22
-14.39%-0.24
Diluted earnings per share
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
74.80%-0.93
-13.61%-0.22
-14.39%-0.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -41.64%3.09M-42.65%3.82M68.49%25.07M78.58%6.93M52.68%6.18M50.87%5.29M93.63%6.67M100.07%14.88M25.56%3.88M158.16%4.05M
Selling and administrative expenses -6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M114.43%7.79M-3.38%1.74M137.85%1.97M
-General and administrative expense -6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M114.43%7.79M-3.38%1.74M137.85%1.97M
Research and development costs -59.99%1.38M-56.49%1.97M150.77%17.78M147.19%5.3M115.89%4.49M128.11%3.46M235.53%4.53M86.36%7.09M65.80%2.14M180.90%2.08M
Operating profit 41.64%-3.09M42.65%-3.82M-68.49%-25.07M-78.58%-6.93M-52.68%-6.18M-50.87%-5.29M-93.63%-6.67M-100.07%-14.88M-25.56%-3.88M-158.16%-4.05M
Net non-operating interest income expense 186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K951.91%547.27K103,983.49%327.86K15,345.44%192.25K
Non-operating interest income 186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K--547.27K--327.86K--192.25K
Other net income (expense) 50.05%-6.11K24.74%3.35K88.93%-55.57K-2,568.41%-61.4K903.20%15.37K97.55%-12.23K316.95%2.69K83.01%-502K-733.70%-2.3K-98.79%1.53K
Special income (charges) ----------0--0--0--------83.81%-500K--0--0
-Less:Other special charges -----------------------------83.81%500K--0----
Other non- operating income (expenses) 50.05%-6.11K24.74%3.35K-2,672.95%-55.57K-2,568.41%-61.4K903.20%15.37K-305,775.00%-12.23K316.95%2.69K-101.62%-2K-733.70%-2.3K-98.79%1.53K
Income before tax 55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M
Income tax
Net income 55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M
Net income continuous Operations 55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M
Minority interest income
Net income attributable to the parent company 55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M-167.14%-3.85M
Basic earnings per share 87.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.474.80%-0.93-13.61%-0.22-14.39%-0.24
Diluted earnings per share 87.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.474.80%-0.93-13.61%-0.22-14.39%-0.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data